Publication:
Molecular markers predicting lymph node metastasis in early esophageal cancer

Thumbnail Image
Files
Plum-30-1193-1202-2015.pdf(2.46 MB)
Date
2015
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Plum, Patrick S. ; Warnecke-Eberz, Ute ; Dhaouadi, Oulfa ; Alakus, Hakan ; Drebber, Uta ; Metzger, Ralf ; Prenze, Klaus L. ; Hölscher, Arnulf H. ; Bollschweiler, Elfriede
item.page.secondaryauthor
item.page.director
Publisher
F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histología
publication.page.editor
publication.page.department
DOI
10.14670/HH-11-618
item.page.type
info:eu-repo/semantics/article
Description
Abstract
y. AIMS: The aim of this study was to identify molecular markers predicting depth of tumor infiltration and presence of lymph node metastasis in early esophageal cancer. METHODS: Between 1996 and 2004, 67 patients with pT1 esophagus cancer underwent esophagectomy. Resected tumors and lymph nodes were analyzed by immunohistochemistry for tissue infiltration, lymph node metastasis (LNM), micrometastasis and extracapsular lymph node infiltration (ELNI). We focused on MMP-2 (matrix-metalloproteinase-2), TIMP2 (tissue inhibitor of metalloproteinase-2), PIM-1 and survivin as the most promising marker candidates. The data was correlated with the patients’ long term followup (median follow-up time 11.4 years). RESULTS: We found 22 pT1a and 45 pT1b carcinomas. None of the mucosal carcinomas, but 58% (26 patients) of the submucosal carcinomas showed lymph node metastasis or micrometastasis. The rate of LNM positively correlated with the depth of tumor infiltration (23% LNM in sm1 tumors and 82% LNM in sm3 tumors). Low grade PIM-1 expression (<30%) was significantly associated with occurrence of LNM (p=0.034) while high expression TIMP-2 (>70%) were detected in submucosal tumors. Logistic regression analysis revealed PIM-1 and Grading G3 as independent risk factors for LNM (p<0.001). Survival of patients with micrometastasis was comparable to those with LNM (median survival: 5.05 years versus 5.52 years). Patients with ELNI had the worst prognosis (median survival: 1.7 years). CONCLUSIONS: PIM-1 is a promising marker for prediction of lymph node metastasis in early esophagus cancer. Extracapsular lymph node infiltration has an independent worse prognostic impact.
publication.page.subject
Esophageal cancer , MMP-2 , TIMP-2 , PIM1 , Survivin , Lymph node metastasis , Extracapsular lymph node infiltration , Immunohistochemistry
Citation
Histology and histopathology, Vol. 30, nº10, (2015)
URI
http://hdl.handle.net/10201/99867
item.page.embargo
Collections
Histology and histopathology Vol.30,nº10 (2015)
Ir a Estadísticas